The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s immunofluorescence assay market report forecasts the immunofluorescence assay market size to grow to $4.1 Billion by 2027, with a CAGR (compound annual growth rate) of almost 7%.

Learn More On The Immunofluorescence Assay Market Report 2023 – https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Immunofluorescence Assay Market Size Forecast
The global immunofluorescence assay market is expected to grow from $2.92 billion in 2022 to $3.14 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The immunofluorescence assay market size is expected to grow to $4.1 billion in 2027 at a CAGR of 6.9%.

North America held the largest immunofluorescence assay market share and was the fastest-growing region in 2022.

Key Immunofluorescence Assay Market Driver ­– Increase In The Prevalence Of Chronic Diseases
For instance, according to the study published by the Centers for Disease Control and Prevention, approximately 6 in 10 adults in the USA are affected by chronic disease, and it is also accounting for $3.8 trillion in annual healthcare costs. Therefore, the increasing prevalence of chronic diseases is expected to boost demand for immunofluorescence assay during forecast period.

Request for A Sample Of The Global Immunofluorescence Assay Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6778&type=smp

Key Immunofluorescence Assay Market Trend – Technological Advancement
The companies operating in immunofluorescence assay are focusing on developing technologically innovative products to meet specific technical demands for the diagnostic of new viruses such as COVID-19 and strengthen their market position. For instance, in March 2022, LumiraDx, a UK-based developer of point-of-care diagnostics, received emergency approval for LumiraDx SARS-CoV-2 Ag Test, a microfluidic immunofluorescence assay, designed for qualitative nucleocapsid protein antigen detection from nasal swab samples.

Immunofluorescence Assay Market Segment
1) By Type: Direct Immunofluorescence, Indirect Immunofluorescence
2) By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories
3) By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases
4) By End User: Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals & Diagnostic Centers

Immunofluorescence Assay Market Major Players and Strategies
Major players in the immunofluorescence assay market are Thermo Fisher Scientific, Inc., Abcam plc, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Agilent Technologies, Becton Dickinson and Company, Maxvision Biosciences Inc., Zyagen, J. Mitra & Co. Pvt. Ltd., AESKU GROUP GmbH, Vector Laboratories, Inc., EpiGentek Group, and Elabscience, Inc.

In March 2021, Fortis Life Sciences, a US-based life sciences company, acquired Bethyl Laboratories for an undisclosed amount. Through this acquisition, Fortis will help Bethyl Laboratories to grow through its expertise in growing businesses and the strong product line difference. Bethyl Laboratories is a US-based premium antibody company.

The Immunofluorescence Assay Global Market Report 2023 covers regional data on immunofluorescence assay market size, immunofluorescence assay market trends and drivers, opportunities, strategies, and immunofluorescence assay market competitor analysis. The countries covered in the immunofluorescence assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The immunofluorescence assay refers to equipment and consumables that operate on a technique, which allows the visualization of specific protein and antigen in infected cells based on their ability to react with specific antibodies by binding a particular antibody chemically conjugated with a fluorescent dye. It is a technique used in the laboratory to diagnose diseases of the skin, kidney, heart, cilia, and other organ systems.

View More Reports Related To The Immunofluorescence Assay Market –
Lateral Flow Immunoassay LFIA Based Rapid Test Global Market Report 2023
Cell Based Assays Global Market Report 2023
Lateral Flow Assays Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: